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Summary
Darier’s Disease (DD), caused by mutations in the endoplasmic reticulum (ER) Ca2+ ATPase 
ATP2A2 (SERCA2b), is a skin disease that exhibits impaired epidermal cell-to-cell adhesion and 
altered differentiation. Although previous studies have shown that keratinocyte Ca2+ sequestration 
and fluxes are controlled by sphingolipid signaling, the role of this signaling pathway in DD 
previously has not been investigated. We show here that sphingosine levels increase and 
sphingosine kinase (SPHK1) expression decreases after inactivating SERCA2b with the specific 
SERCA2 inhibitors thapsigargin (TG) or siRNA to SERCA2b. Conversely, inhibiting sphingosine 
lyase rescues the defects in keratinocyte differentiation, E-cadherin localization, Desmoplakin 
(DP) translocation, and ER Ca2+ sequestration seen in TG-treated keratinocytes. To our 
knowledge, it was previously unreported that the keratinocyte sphingolipid and Ca2+ signaling 
pathways intersect in ATP2A2- controlled ER Ca2+ sequestration, E-cadherin and desmoplakin 
localization and Ca2+ - controlled differentiation, and thus may be important mediators in DD.
Keywords
Darier’s Disease; keratinocyte; calcium; sphingolipid; acantholysis; apoptosis; E-cadherin; 
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Introduction
Darier’s disease (DD) (Darier, 2000,White, 1889) is an inherited skin disease characterized 
by keratotic papules and plaques found mostly in skin flexures and on the chest, upper back, 
face and scalp. Histopathology of DD skin reveals impaired differentiation, acantholysis and 
pathologic apoptosis. Patients with DD also have been reported to suffer from 
neuropsychiatric disease (Gordon-Smith, et al., 2010). Mutations in the endoplasmic 
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reticulum (ER) Ca2+ ATPase (gene ATP2A2; protein SERCA2b), which sequesters Ca2+ in 
the ER, cause DD (Sakuntabhai, et al., 1999a, Sakuntabhai, et al., 1999b). The disease is 
thought to be caused by haploinsufficiency (Foggia, et al., 2006). Treatment for DD largely 
has been empiric, and is only partially effective in some patients, although a variety of 
pharmacologic and physical agents have been proposed (Kragballe, 1995; Reuter, et al., 
2007; Stewart and Yell, 2008; Cooper and Burge, 2003).
Ca2+ signaling is implicated in keratinocyte and epidermal differentiation, cell-to-cell 
adhesion and apoptosis. Normal Ca2+ signaling requires both IP3-mediated ER and Golgi 
Ca2+ release and Ca2+ influx though Ca2+ -permeable ion channels, leading to transcription 
of differentiation-specific genes (Bikle, et al., 2001) and stimulating formation of adherens 
junctions containing E-cadherin (Green, et al., 2010). Well known as a structural protein, E-
cadherin also recently has been shown to have important signaling functions, as two kinases 
contained within the E-cadherin complex (Xie and Bikle, 2007; Xie, et al., 2009) maintain 
the prolonged Ca2+ increase essential for calcium induced differentiation.
Sphingolipid metabolism (fig 1A) constitutes a complementary Ca2+ signaling system in 
keratinocytes. Heightened levels of intracellular Sphingosine-1-phosphate (S1P) increase 
cytosolic Ca2+ levels by direct mobilization of Ca2+ from Thapsigargin (TG) sensitive stores 
(Meyer zu Heringdorf, et al., 2003), while increases in extracellular S1P concentrations 
activate Store Operated Calcium Entry (SOCE), through activation of G-protein coupled 
receptors (Mehta, et al., 2005). In keratinocytes, increased intracellular S1P enhances 
keratinocyte growth and differentiation, and blocks apoptosis (Hong, et al., 2008; Lichte, et 
al., 2008). Activating sphingosine kinase (SPHK1) increases intracellular S1P; thus, agents 
that activate this enzyme enhance expression of the differentiation markers filaggrin and 
involucrin in HaCAT keratinocytes (Hong, et al., 2008). In contrast, blocking SPHK1 
increases apoptosis in UVB-treated keratinocytes (Uchida, et al., 2010). S1P levels also can 
be increased by preventing S1P breakdown (Figure 1A) via Sphingosine phosphate lyase 
(SGPL1) (Reviewed by Kumar and Saba, 2009).
We show here that the sphingolipid and Ca2+ signaling pathways intersect in controlling 
SERCA2- ER Ca2+ sequestration. SERCA2b inhibition decreases SPHK1 expression and 
reproduces the defects in cell growth, adhesion and differentiation seen in DD. In contrast, 
inhibiting SGPL1 compensates for decreased SPHK1 and rescues or ameliorates defects in 
differentiation, E-cadherin processing, desmoplakin translocation, and ER Ca2+ 
sequestration. Currently, SGPL1 is being targeted as possible therapeutic target for 
rheumatologic disease and multiple sclerosis. These therapeutic agents could also prove 
valuable as therapy for DD.
Results and Discussion
Increased sphingosine can enhance cell death/cell cycle arrest, previously reported in a 
canine model of DD (Muller, et al., 2006), while increased levels of S1P promote cell 
growth and viability. The relative amounts of these lipids are determined by the activity of 
SPHK1, which metabolizes sphingosine to S1P; and SGPL1, which degrades S1P to 
phosphoethanolamine and hexadecanol (Fig. 1A). Because abnormal sphingolipid signaling 
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and DD share impaired cell differentiation, cell survival and calcium signaling, we first 
examined whether pharmacologically inactivating the ER Ca2+ ATPase SERCA2b could 
alter sphingolipid metabolism. We found that low concentrations of TG (100nM) increased 
sphingosine concentrations (Fig. 1B). We were able to detect decreased sphingosine kinase 
mRNA expression after treatment with even lower TG concentrations (10-100nM) (Fig. 1C). 
A similar decrease in SPHK1 expression was seen after inactivating SERCA2b with siRNA 
(Fig. 1C). Both siRNA and TG were used to impair SERCA2 function in subsequent 
experiments. The dose of SERCA2b siRNA used for these experiments was chosen to 
reproduce the average 50% reduction in SERCA2b expression seen in DD patients (Foggia, 
et al., 2006) (figure S1). In the same paper, the authors report an average basal level of ER 
calcium for DD cells that is 60% lower than control as observed by transient cytosolic 
calcium increase after TG exposure. We observed that a similar decrease in ER calcium was 
obtained by treating cells with 10nM TG (Celli, et al., 2010, and figure 7c) and we therefore 
used this concentration for the functional studies presented in this report.
The ER Ca2+ store is important for normal keratinocyte signaling and differentiation 
(Callewaert, et al., 2003; Foggia, et al., 2006). Previous experiments demonstrated that early 
differentiation protein expression is inhibited by disabling the ER Ca2+ ATPase (Li, et al., 
1995b; Li, et al., 1995a). Early differentiation proteins also are decreased in SERCA2 
knockout mouse keratinocytes (Hong, et al., 2010), and defects in E-cadherin localization 
have been reported in human DD (Tada and Hashimoto, 1998). Decreased E-cadherin levels 
and/or trafficking may directly lead to decreased cell-to-cell adhesion via impaired 
formation of adherens junctions and may additionally impair IP3 mediated keratinocyte 
Ca2+ signaling because the E-cadherin complex formation in the membrane is essential for 
PLCγ1 activity (Xie and Bikle, 2007; Xie, et al., 2009). We therefore assessed whether 
modulating the sphingolipid pathway could reproduce or rescue defects in keratinocyte 
differentiation and E-cadherin expression or localization. We observed abnormal 
keratinocyte morphology and growth 24 hours (data not shown) and 48 hours after TG 
treatment (Fig. 2D). Inhibition of SGPL1 with siRNA rescued these defects (Fig 2F). 
Western blotting showed that SERCA2 inhibition with TG also led to defects in involucrin 
protein synthesis and E-cadherin protein synthesis and processing. These defects could be 
normalized or ameliorated by inhibiting SGPL1 synthesis (Fig. 3). We found that SGPL1 
inhibition was more effective in normalizing the defects in involucrin and E-cadherin 
expression caused by lower doses of TG (10 nM) than after higher (100nM) TG (data not 
shown), likely because the effects of SERCA2 inhibition became irreversible at higher 
doses. Treatment with exogenous S1P had no effect (Fig. S3). Vitamin D and cannabinoid 
analogues also were ineffective (Fig. S3).
The additional, higher molecular weight band seen on immunoblots after TG treatment 
suggested that E-cadherin intracellular processing and localization might also be disrupted 
when ER Ca2+ stores were depleted, similar to what has previously been reported for DD 
(Hakuno, et al., 2000). To test this, we localized E-cadherin first using an antibody that 
selectively binds to the extracellular epitope (Fig. 4A-D). E-cadherin normally responds to 
raised extracellular Ca2+ by forming continuous, fine intercellular strands (Fig. 4A). TG 
treatment lead to a dose-dependent disruption in these cell-to-cell contacts, with E-cadherin 
localization becoming coarse and irregular at very low (10nM) TG concentrations (Fig. 4B), 
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and discontinuous at 100 nM TG concentrations (data not shown). SGPL1 inhibition 
normalized E-cadherin localization at 10 nM TG (Fig. 2D), but only partially rescued TG-
induced E-cadherin disruption at the 100 nM dose (not shown). Treatment with scrambled 
siRNA had no significant effect (Fig. 4C). These data suggest that E-cadherin is not properly 
localized to the plasma membrane after SERCA2 inhibition.
To test whether SERCA2 inhibition lead to defective E-cadherin, we next localized E-
cadherin using an antibody that binds to an intracellular E-cadherin epitope. After raising 
extracellular Ca2+, the vast majority of E-cadherin was found at cell-to-cell junctions in 
normal keratinocytes (Fig. 4E) with only punctuate foci of intracellular E-cadherin seen. 
After treatment with 10 nM TG, extracellular E-cadherin again appeared irregular and 
beaded (Fig. 4F). In addition, perinuclear aggregates of E-cadherin also were seen (Fig. 4F), 
suggesting that ER Ca2+ depletion leads to intracellular E-cadherin accumulation. This 
process also was dose-dependent, and the vast majority of E-cadherin was localized 
intracellularly after treatment with 100 nM TG (not shown). As above, inhibition of SGPL1 
was able to normalize E-cadherin localization in keratinocytes treated with 10 nM TG (Fig.
4H), but only partially rescued keratinocytes treated with the higher 100 nM TG (not 
shown). Treatment with scrambled siRNA did not rescue the defects caused by TG 
treatment (Fig. 4G).
Downregulation of SERCA2b expression by siRNA resulted in a similar pattern of 
intracellular and extracellular E-cadherin staining (Fig. 5D and J respectively) that could be 
normalized by SGPL1 siRNA treatment (Fig. 5E and K). Treatment with a scrambled 
siRNA sequence had no effect (Fig. 5F and L).
These studies demonstrate that E-cadherin requires normal ER Ca2+ stores to properly 
localize to the plasma membrane, and that the defects seen in cell-to-cell adhesion in DD 
may be due to defective E-cadherin localization.
To further investigate the effects of SERCA2 inactivation on cell to cell junctions, we 
assessed the effect of 10 nM TG on desmoplakin (DP) localization, which also is disrupted 
following SERCA2 inactivation (Hobbs, et al., 2011). In agreement with this previous 
report, we also observed DP localization at the cell to cell borders within 3 hours after 
raising extracellular Ca2+ in control cells (Fig. 6A-C). 48 hours after raising extracellular 
Ca2+, DP was almost entirely localized to cell-to-cell borders (Fig. 6G-I). Like E-cadherin, 
TG disrupted DP localization in a dose-dependent manner. Cells treated with 10 nM TG are 
shown in figure 6D and J, and cells treated with 100 nM TG are shown for comparison in 
Fig. S5. DP staining was mostly intracellular in TG-treated cells. Defects in DP staining and 
gaps between cells were noted at both the 3 and 48 hours time points (Fig. 6D and J 
respectively). Treatment with SGPL1 siRNA completely rescued DP localization 48 hours 
after calcium switch, but only partially at the earlier 3 hour time point (Fig. 6K and E 
respectively). Treatment with scrambled siRNA did not rescue the abnormal DP localization 
(figure 6C, F, I, L). SGPL1 siRNA also partially rescued DP localization in cells treated 
with 100nM TG (Fig. S5).
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We used the ER-targeted Ca2+ sensor D1ER to monitor ER Ca2+ depletion after SERCA2 
inhibition, and to assess whether SGPL1 inhibition could ameliorate this loss. Figure 7A and 
figure 7B present the data as average FRET ratios and average calcium concentrations 
respectively. A decrease in FRET ratio indicates lower Ca2+ concentrations. FRET ratios 
were converted into calcium concentration following the protocol in (Rudolf, et al., 2006). 
siRNA transfection alone, with either a scrambled sequence or SGPL1 siRNA, leads to a 
small decrease in ER calcium levels. In agreement with a previous report (Celli, et al., 
2010), treatment with 10nM thapsigargin caused a dramatic drop in ER calcium 
concentration in both untreated and scrambled siRNA transfected samples. However, 
treatment with 10nM TG had no significant effect on ER Ca2+ in cells pretreated with 
SGPL1 siRNA (Fig. 7A and B). TG treatment produced more than a 50% drop in ER Ca2+ 
concentration in both untreated keratinocytes and scrambled siRNA-transfected 
keratinocytes (Fig. 7C). In contrast, SGPL1 inhibition prevented this TG- induced Ca2+ loss 
(Fig. 7C). These data suggest that modulating sphingosine metabolism may normalize TG-
induced abnormalities in keratinocyte differentiation and cell-to-cell adhesion by mitigating 
ER Ca2+ loss after SERCA2 inactivation. 100 nM TG almost completely emptied ER Ca2+ 
stores and could not be rescued by SGPL1 inhibition (data not shown). SGPL1 inhibition did 
not change SERCA2 protein levels or SPHK1 mRNA expression, suggesting that Ca2+ was 
normalized by a mechanism independent of SERCA2 or SPHK1 synthesis (Fig. S1 and S2).
This report demonstrates that inhibiting SGPL1 rescues ER Ca2+ depletion-induced defects 
in keratinocyte differentiation and adhesion, and restores ER Ca2+ stores depleted by 
SERCA2 inhibition. How sphingosine metabolism and SERCA2 Ca2+ signaling interact in 
directing keratinocyte adhesion and differentiation is not yet well defined. Certainly, the 
actions of exogenous S1P in controlling intracellular Ca2+ have been studied extensively. 
However, we found that exogenous S1P was ineffective in rescuing adhesion and 
differentiation defects caused by SERCA2b inactivation (Fig. S3). These data suggest that 
generation of intracellular S1P is essential for rescuing the DD phenotype. Alternatively, 
extracellular S1P-stimulated Ca2+ release from the ER may be blunted when these stores 
already are depleted due to SERCA2 dysfunction. Exposure to increased intracellular S1P 
levels, on the other hand, has been shown to increase calcium levels in TG sensitive stores 
and to mobilize calcium from these stores into the cytosol, independently of the plasma 
membrane G-protein coupled S1P receptor (Claas, et al., 2010; Meyer zu Heringdorf, et al., 
2003).
In a recent paper, Calloway et al (Calloway, et al., 2009) found that treatment of RBL mast 
cells with sphingosine and its positively charged analogues inhibited the Ca2+ influx via 
SOCE usually seen after TG treatment, by flipping to the inner leaflet of the plasma 
membrane and preventing Ora1/CRACM1 from interacting with STIM1. Thus, SERCA2b 
inactivation might cause not only ER Ca2+ depletion, but also lead to increased intracellular 
sphingosine, via SPHK1 inhibition. The increased sphingosine then might interfere with 
Ora/CRACM1/STIM interaction, exacerbating the low ER Ca2+ caused by SERCA2b loss.
We chose to study the effects of ER calcium depletion and SGPL1 down-regulation on E-
cadherin because this protein has both a structural function and a role in calcium signaling 
(Xie and Bikle, 2007; Xie, et al., 2009). Moreover, calcium dependent E-cadherin 
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aggregation at cell-to-cell adhesion points is known to be perturbed in DD (Tada and 
Hashimoto, 1998). In contrast to a previous study (Hobbs, et al., 2011) our experiments 
demonstrated that E-cadherin localization was disrupted after SERCA2 inhibition. This 
discrepancy may be explained by the longer timecourse (24–48 hours vs. 3 hours) used in 
our studies, based on previous findings that E-cadherin continues to aggregate and complex 
at cell-to-cell junctions for at least 7–20 hours (Vasioukhin, et al., 2000). 
Immunofluorescence micrographs of SERCA2 siRNA treated cells harvested 3 hours after 
calcium switch do not show significant defects in E-cadherin localization (Fig. S4) as 
compared to the longer time points, thus lending support to this hypothesis.
SGPL1 inhibition also normalized desmoplakin (DP) trafficking, which has been implicated 
in DD (Dhitavat, et al., 2003; Hobbs, et al., 2011). These studies suggest that modulating the 
sphingolipid pathway may ameliorate the defective cell-to-cell adhesion that is a hallmark of 
DD.
We studied cells treated with thapsigargin or siRNA against SERCA2 in lieu of DD 
keratinocytes, as previous studies conducted on DD keratinocytes revealed a wide 
heterogeneity in calcium mobilization in these cells (Foggia, et al., 2006). While further 
investigation on the effects of SGPL1 inhibition in DD cells is needed, we show here that 
reversing SERCA2 inhibition caused by thapsigargin or SERCA2 siRNA ameliorates the 
junctional and differentiation defects that are known to underlie DD pathology.
MATERIALS AND METHODS
Cell Culture
Normal human keratinocytes, passage 2-3, were plated in 0.03 mM Ca+2 154 CF media 
(Cascade, Life Sciences, NY). For experiments where TG was used, cells were treated with 
either scrambled siRNA (as a negative control) or siRNA against SGPL1 (Hs_SGPL1_2 
Flexitube, Quiagen, Valencia, CA) when 80% confluent. 8 hours after siRNA treatment, 
thapsigargin at a final concentration of 10 or 100 nM, was added to some of the cells for 2 
hours. The media was then replaced with 1.2 mM Ca+2 154 CF (Cascade, Life Sciences, 
NY), to induce differentiation. For experiments where siRNA against SERCA2 (silencing 
sequence: AAGCAGGACATCAATGAGCAA) was used, cells were transfected with 
siRNA against SERCA2, or a scrambled siRNA sequence for control, when cells were 60% 
confluent and treated with SGPL1 siRNA, or with a scrambled siRNA for control, 24 hours 
after. Hyperfect transfection reagent (Quiagen, Valencia, CA) was used for all siRNA 
transfections. Cells were harvested at time points noted in each figure after thapsigargin 
treatment. Vehicle (for TG) or scrambled siRNA were used as controls.
ER calcium measurements
60% confluent cells were transfected with D1ER (gift of Prof. Tsien’s laboratory) using 
Mirrus Keratinocyte Transit lipid reagent, according to the manufacturer’s protocol. 24 
hours after transfection, cells were treated with SGPL1 siRNA or scrambled siRNA and TG 
as described above. Dual channel fluorescence measurements were performed 24 hours later 
using a Zeiss LSM Meta confocal system (Carl Zeiss Inc., NY). Calibration of the Calcium 
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sensitivity range of the probe and conversion of the FRET ratio into Calcium concentrations 
was performed following the protocol in (Palmer and Tsien, 2006; Rudolf, et al., 2006).
Sphingosine Analysis
Total lipids were extracted from keratinocytes and then sphingoid bases were converted to 
o-phthalaldehyde derivatives after dephosphorylation with alkaline phosphatase as 
previously reported (Min, et al., 2002). Sphingoid base o-phthalaldehyde derivatives were 
separated on C18 reverse phase HPLC column (Luna C18(2), 250 x 4.6 mm, 5μm, 
Phenomenex, Torrance, CA) using methanol:water (9:1) (v/v) with a 1 ml/min flow. 
Fluorescence intensity was monitored at Ex 360 nm and Em 430 nm. The sphingoid base 
content was reported as pmol per mg of protein.
Immunohistochemistry
Normal human keratinocytes were treated as described above (see Cell Culture). Samples 
were formaldehyde-fixed. Cells were stained with an antibody that stained both intracellular 
and extracellular E-cadherin (36/E-Cadherin BD Transduction Laboratories, Sparks, MD), 
or only the extracellular epitope of E-cadherin (HECD-1, abcam, Cambridge, MA). For 
desmoplakin immunofluorescence we used a mouse monoclonal antibody (1G4 gift of Dr. 
Kathy Green).
Photomicrographs shown in figure 4 were taken on a Zeiss 510 Meta confocal microscope 
(Carl Zeiss Inc. NY). Identical laser power and detector gain levels were used for all images. 
Photomicrographs in figures 5 and 6 were taken using a Zeiss observer/spinning disk 
confocal system (Carl Zeiss Inc. NY). Identical laser power and detector gain levels were 
used for all images.
Western Blotting
Cells were homogenized, and proteins were isolated using RIPA buffer (Sigma-Aldrich, 
Saint Louis, MO) containing protease inhibitors (Roche Applied Science, Indianapolis, IN). 
Protein quantification for equal loading was made with Thermo Scientific Pierce’s BCA 
assay kit. SDS-PAGE and transfer was performed using NuPAGE Novex 4-12% sodium 
dodecyl sulfate-polyacrylamide gels and nitrocellulose membranes according to Invitrogen’s 
NuPAGE protocol. Membranes were blocked in PBS with 5% non-fat dry milk and 0.05% 
Tween-20 and incubated with the following primary antibodies and dilutions: anti-
Involucrin (Sigma Aldrich, Saint Louis, MO) at 1:100, anti-Ecadherin (Invitrogen, Life 
Science, NY) at 1:500, and anti-β-Actin-HRP (Sigma-Aldrich, Saint Louis, MO) at 1:30,000 
anti-SERCA2. Chemiluminescent detection was performed with ECL Plus detection reagent 
(Thermo Scientific Pierce, Waltham, MA) using the Fujifilm LAS-3000 imaging system.
Quantitative PCR
All cDNA was generated using Roche Applied Science’s Transcriptor first strand cDNA 
synthesis kit. Quantitative PCR (QPCR) was performed using TaqMan fast universal PCR 
master mix and the ABI 7900HT real-time PCR machine (Applied Biosystems, Life 
sciences, NY) and target genes were normalized to GAPDH (primers and dual-labeled 
probes from Applied Biosystems). Human SPHK1 primers and probes used: 
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CTGTCTGCTCCGAGGACTG forward, CGTGGTTCTTACACCACTGC reverse, 
TGACCTGCTACCTCGGCCGC probe.
Statistical Analysis
Data were analyzed using the paired, two-tailed Students T test and one-way ANOVA.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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SPKH1 Sphingosine Kinase 1
SGPL1 Sphingosine Lyase
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Figure 1. Sphingosine Metabolism is Controlled by SERCA2
A. Sphingosine metabolism in keratinocytes. B. SERCA2 Inactivation Increases 
Sphingosine. Normal human keratinocytes were treated with TG 100 nM for 2 hours. 
Sphingosine levels were measured with HPLC (see Materials and Methods) 24 and 48 hours 
after TG treatment. Data are presented as the mean ± SD. N=3 for each data point. * = 
p<0.05 C. SPHK1 Expression is Decreased After SERCA2 Inhibition. Normal human 
keratinocytes were treated with 10 and 100 nM TG for 2 hours, washed, recultured and 
harvested at 24 (grey bars) and 48 (black bars) hours. In separate experiments, normal 
human keratinocytes were treated with siRNA to SERCA2b, and then harvested at 48 hours 
(marble bars). Control keratinocytes were treated with TG vehicle or scrambled siRNA 
(marble bar) and normalized to 1. SPHK1 expression was assessed with RT-PCR (see 
Materials and Methods).
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Figure 2. Defects in Keratinocyte Morphology, Induced by SERCA2 Inhibition, are Normalized 
by Inhibiting SGPL1
Human Keratinocytes were cultured in growth media containing 0.06 mM Ca2+. When 80% 
confluent, some of the cells were transfected with siRNA against SGPL1 for 8 hours, then 
10 nM (final concentration) TG was added. After two hours exposure to TG cells were 
washed and fed with growth media containing 1.2 mM Ca2+. Images were acquired 48 hours 
after raising extracellular Ca2+. A. Vehicle treated cells showing normal morphology: cells 
are tightly packed and flattened after 48 hours in high calcium; B and C) cells treated with 
scrambled siRNA or siRNA against SGPL1 show no morphological difference from 
untreated cells. D) 10 nM TG treatment produces larger keratinocytes that have not 
flattened. E) Treatment with scrambled siRNA has no effect on TG treated cells F) cells 
treated with both TG and siRNA to SGPL1 demonstrate a morphology similar to control 
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keratinocytes. All images were acquired at the same magnification. The scale bar in panel A 
indicates 50μm.
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Figure 3. Defects in Involucrin and E-cadherin synthesis and Processing Are Normalized by 
Inhibiting SGPL1
Human Keratinocytes were cultured and treated as in Figure 2, above. Cells were harvested 
48 hours after raising extracellular Ca2+. E-cadherin and involucrin protein levels were 
assessed using Western blotting (see Methods).
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Figure 4. Defects in E-cadherin localization Are Normalized by Inhibiting SGPL1
A-D) Keratinocytes cultured in 1.2 mM Ca2+ for 48 hours were stained with an E-cadherin 
antibody that recognizes an extracellular epitope. E-H) Keratinocytes cultured in 1.2 mM 
Ca2+ for 48 hours stained with an E-cadherin antibody that recognizes an intracellular 
epitope. (A and E) Control keratinocytes. (B and F) After treatment with 10 nM TG, 
extracellular E-cadherin staining (B) is discontinuous, with filamentous strands (arrows). (F) 
Perinuclear accumulation of E-cadherin is seen (arrows). (C and G) Scrambled siRNA does 
not rescue intracellular or extracellular E-cadherin localization (arrows). (D and H) SGPL1 
inhibition with siRNA restores continuous, fine extracellular E-cadherin localization (D) and 
reverses the E-cadherin intracellular retention (H) seen after SERCA2 inhibition with TG.
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Figure 5. Defects in E-cadherin localization following downregulation of SERCA2b expression 
with siRNA Are Normalized by Inhibiting SGPL1
A-F) Extracellular E-cadherin staining. A-C) Untreated, SGPL1 siRNA, and scrambled 
siRNA treated control cells show linear, smooth staining at the cell-to-cell borders; D) 
Treatment with SERCA2 siRNA results in rough, discontinuous, filamentous borders, and 
larger cells similar to TG treated cells (compare to Figure 4, above); E) SGPL1 inhibition 
with siRNA restores normal E-cadherin localization; F) Scrambled siRNA has no effect.
G-L) Intracellular E-cadherin staining; G-I) Untreated, SGPL1 siRNA, and scrambled 
siRNA treated control cells show normal, minimal intracellular retention of E-cadherin; J) 
Cells treated with siRNA to SERCA2b demonstrate more diffuse intracellular staining, 
irregular cell borders and larger cells; K) SGPL1 siRNA treatment restores normal E-
cadherin localization; L) scrambled siRNA has no effect.
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Figure 6. Defects in Desmoplakin (DP) localization, Caused by SERCA2 inactivation with TG, 
Are Normalized by Inhibiting SGPL1
Desmoplakin staining of human keratinocytes treated with 10nM TG, 3hours (A-F) and 48 
hours (G-L) after raising extracellular Ca2+. In control (A), SGPL1 (B) and scrambled 
siRNA-treated cells (C), DP accumulation at cell-to-cell borders is evident within 3 hours 
after raising extracellular Ca2+. (G-I) 48 hours after raising extracellular Ca2+, DP localizes 
exclusively at the cell to cell borders in control (G) , SGPL1 siRNA (H) and scrambled 
siRNA-treated (I) cells. Treatment with 10 nM TG reduces DP staining at the cell borders 
three hours after raising extracellular Ca2+ (D) and intracellular retention of DP is evident at 
48 hours (J); SGPL1 inhibition with siRNA improves DP localization at 3 hrs (E), but 
complete normalization of DP localization is seen only at 48 hours (K). Scrambled siRNA 
had no effect (F and L).
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Figure 7. Defects in ER Ca2+ Sequestration are Induced by ER SERCA2 Inhibition, and are 
Normalized by Inhibiting SGPL1
Primary normal human keratinocytes were transfected with the ER-targeted Ca2+ sensor 
D1ER (see Methods). Cells also were transfected with SGPL1 siRNA or scrambled siRNA 
as a control. 8 hours after siRNA transfection, cells were treated with 10 nM thapsigargin for 
two hours. The cells then were washed, and incubated in high calcium media for an 
additional 24 hours. A) average FRET ratio; B) average ER Ca2+ concentration; C) Relative 
Ca2+ changes between control (black bars) and TG treated cells (grey bars) in untreated, 
scrambled siRNA, and SGPL1 siRNA treated samples. Data are presented as the mean +/− 
s.e.m. N=15–29 cells from two independent sets of experiments in each group. Significance 
Celli et al. Page 18
J Invest Dermatol. Author manuscript; available in PMC 2012 October 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
was calculated using a one-way ANOVA. Distributions with p<0.05 were assumed as 
statistically different.
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